Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, F.
Right arrow Articles by Hanafusa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, F.
Right arrow Articles by Hanafusa, T.
Related Collections
Right arrow Outcome research
Right arrow Amyotrophic lateral sclerosis
Right arrow Clinical trials Methodology/study design
NEUROLOGY 2006;66:265-267
© 2006 American Academy of Neurology
Brief Communications

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS

F. Kimura, MD, PhD, C. Fujimura, MD, S. Ishida, MD, PhD, H. Nakajima, MD, PhD, D. Furutama, MD, PhD, H. Uehara, MD, K. Shinoda, MD, PhD, M. Sugino, MD, PhD and T. Hanafusa, MD, PhD

From the Division of Neurology, First Department of Internal Medicine, Osaka Medical College, Osaka, Japan.

Address correspondence and reprint requests to Dr. Fumiharu Kimura, Division of Neurology, First Department of Internal Medicine, Osaka Medical College, Daigaku-machi 2-7, Takatsukishi, Osaka, Japan 569-8686; e-mail: in1110{at}poh.osaka-med.ac.jp

The authors calculated the progression rate ({Delta}FS) using the total revised ALS Functional Rating Scale (ALSFRS-R) and symptom duration at diagnosis in 82 Japanese patients with ALS. Survival (death or tracheostomy) differed significantly with the {Delta}FS and postdiagnostic period according to log-rank testing, but Cox proportional hazards modeling revealed no strong association between total ALSFRS-R and mortality, suggesting that the {Delta}FS provides an additional predictive index beyond ALSFRS-R alone.

Supported by grants from Grants-in-Aid for Scientific Research (C) (15590916) from the Japanese Ministry of Education, Science and Culture and The Osaka Medical Research Foundation for Incurable Diseases.

Disclosure: The authors report no conflicts of interest.

Received March 9, 2005. Accepted in final form October 7, 2005.




This article has been cited by other articles:


Home page
 NeurologyHome page
C. Armon, V.P.M. Dal Bello-Haas, J.M. Florence, A.D. Kloos, J. Scheirbecker, G. Lopate, S.M. Hayes, E.P. Pioro, and H. Mitsumoto
A RANDOMIZED CONTROLLED TRIAL OF RESISTANCE EXERCISE IN INDIVIDUALS WITH ALS
Neurology, September 9, 2008; 71(11): 864 - 866.
[Full Text] [PDF]

Home page
 NeurologyHome page
Y. K. Cheung, P. H. Gordon, and B. Levin
Selecting promising ALS therapies in clinical trials
Neurology, November 28, 2006; 67(10): 1748 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. H. Gordon, Y. K. Cheung, and F. Kimura
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Neurology, October 10, 2006; 67(7): 1314 - 1315.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
Paul H. Gordon, et al.
Neurology Online, 24 May 2006 [Full text]
Reply from the Author
Fumiharu Kimura
Neurology Online, 24 May 2006 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.